Patents Assigned to HASTIM
  • Autologous Cancer Vaccines
    Publication number: 20240148846
    Abstract: The invention relates to an autologous cancer vaccine and also to the method for producing same comprising the following steps: a) extracting the proteins contained in a serum or plasma sample obtained from a patient suffering from cancer; and b) bringing the proteins extracted in step a) into contact with particles of hydroxyapatite and/or tricalcium phosphate.
    Type: Application
    Filed: November 3, 2023
    Publication date: May 9, 2024
    Applicant: HASTIM
    Inventors: Patrick Frayssinet, Nicole Rouquet
  • Autologous cancer vaccines
    Patent number: 11839648
    Abstract: The invention relates to an autologous cancer vaccine and also to the method for producing same comprising the following steps: a) extracting the proteins contained in a serum or plasma sample obtained from a patient suffering from cancer; and b) bringing the proteins extracted in step a) into contact with particles of hydroxyapatite and/or tricalcium phosphate.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: December 12, 2023
    Assignee: HASTIM
    Inventors: Patrick Frayssinet, Nicole Rouquet